Attached files
| file | filename |
|---|---|
| EX-4.10 - EX-4.10 - Altimmune, Inc. | alt-ex410_6.htm |
| EX-10.15 - EX-10.15 - Altimmune, Inc. | alt-ex1015_726.htm |
| 10-K - 10-K - Altimmune, Inc. | alt-10k_20201231.htm |
| EX-32.2 - EX-32.2 - Altimmune, Inc. | alt-ex322_8.htm |
| EX-32.1 - EX-32.1 - Altimmune, Inc. | alt-ex321_12.htm |
| EX-31.2 - EX-31.2 - Altimmune, Inc. | alt-ex312_9.htm |
| EX-31.1 - EX-31.1 - Altimmune, Inc. | alt-ex311_11.htm |
| EX-21 - EX-21 - Altimmune, Inc. | alt-ex21_7.htm |
| EX-10.22 - EX-10.22 - Altimmune, Inc. | alt-ex1022_727.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
Form |
Registration Number |
Date Filed |
|
S-3 |
333-251858 |
12/31/2020 |
|
S-8 |
333-248232 |
8/21/2020 |
|
S-8 |
333-233273 |
8/14/2019 |
|
S-8 |
333-230722 |
4/4/2019 |
|
S-8 |
333-228623 |
11/30/2018 |
|
S-8 |
333-217846 |
5/10/2017 |
|
S-8 |
333-214765 |
11/22/2016 |
|
S-8 |
333-156371 |
12/19/2008 |
of our report dated February 25, 2021, with respect to the consolidated financial statements of Altimmune, Inc., included in this Annual Report (Form 10-K) of Altimmune, Inc. for the year ended December 31, 2020.
|
/s/ Ernst & Young LLP |
|
|
|
|
|
Baltimore, Maryland |
|
|
February 25, 2021 |